Leerink Partners Reiterates Outperform on BrightSpring Health (BTSG) after Investor Day
Leerink Partners analyst Whit Mayo reiterated an Outperform rating and $49.00 price target on BrightSpring Health (NASDAQ: BTSG)The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
